Dispensing of HIV and Hepatitis C Antivirals During COVID-19: An Interrupted Time-Series Analysis of U.S. National Data

INTRODUCTION: Little is known about the potential changes in the dispensation of life-saving hepatitis C virus (HCV) and HIV antivirals after the initial U.S. outbreak of COVID-19. The objective of this study was to describe the immediate and 1-year impacts of the U.S. outbreak of COVID-19 on monthl...

Descripción completa

Detalles Bibliográficos
Autores principales: Levengood, Timothy W., Aronsohn, Andrew I., Chua, Kao-Ping, Conti, Rena M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal of Preventive Medicine. Published by Elsevier Inc. 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119965/
https://www.ncbi.nlm.nih.gov/pubmed/35738958
http://dx.doi.org/10.1016/j.amepre.2022.04.024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119965/
https://www.ncbi.nlm.nih.gov/pubmed/35738958
http://dx.doi.org/10.1016/j.amepre.2022.04.024

Ejemplares similares